Menicon Co Ltd
OTC: MECNY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Koji Kawaura
- Employees
- 4,325
- Headquarters
- Nagoya, United States
- IPO year
- 2021
- Market cap
- $26.9B
- Website
- http://www.menicon.co.jp
Loading MECNY…
Loading profile data…Frequently asked questions about MECNY
What does Menicon Co Ltd (MECNY) do?
Menicon Co Ltd operates as a specialized manufacturer within the contact lens industry. Its operations involve the worldwide manufacturing, distribution, and trade (both export and import) of contact lenses, in addition to other medical merchandise. The company also produces and sells medical instruments, supplies various medical provisions, and...
Where does MECNY trade?
Menicon Co Ltd (MECNY) trades on the Other OTC.
What sector is MECNY in?
Menicon Co Ltd (MECNY) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Menicon Co Ltd?
Koji Kawaura is the chief executive officer of Menicon Co Ltd (MECNY).
Where is Menicon Co Ltd headquartered?
Menicon Co Ltd is headquartered in United States.
Does MECNY pay a dividend?
Menicon Co Ltd (MECNY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MECNY go public?
Menicon Co Ltd (MECNY) completed its initial public offering in 2021.
Is MECNY an ADR?
Yes — MECNY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Menicon Co Ltd reporting and dividends follow the underlying issuer.